Microbot Medical specializes in transformational robotic technologies, focused primarily on the endovascular space. Our LIBERTY Robotic System is the world's first single-use endovascular robotic system focused on increasing access to robotic technology and revolutionizing the way endovascular procedures are performed.
Total Fundraised$60.7M
Post-IPO Equity
Grant
Content Locked
Login or Register a FREE account to continue browsing our content
Content Locked
Login or Register a FREE account to continue browsing our content
Funding Round | Announced Date | Disclosed Investors | Round Amount (USD) |
---|---|---|---|
Post-IPO Equity | 09 Jun 2017 | Undisclosed | 10.1M |
Grant | 08 Nov 2017 | Israel Innovation Authority | 735K 1 Investors |
Grant | 01 Jun 2018 | EASME | 80K 1 Investors |
Content Locked
Login or Register a FREE account to continue browsing our content